World Wellness Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World Wellness Times.

Press releases published on October 30, 2026

Top Offroad Motorcycle Manufacturer: Shandong Tuowei Locomotive Co., Ltd. Expands Its Market Presence
Pukka Unveils Its Bestselling Organic Tea Advent Calendar for Christmas 2026
The Orchard, Queens’ Tallest Tower with 800+ Residences, Surpasses 90% Leased in Only Nine Months as Tokimo, Intuit and Mollytea Join Development’s Retail Offerings
Eagle Pharmaceuticals Board Extends Limited Duration Stockholder Rights Plan
Changan Supports Youth Education and Community Sport through Changan City Stadium in Casablanca
Soda Peak Gummies Publishes Informational Guide on Honey Trick for Men, Baking SodaPeak Practices, and Supplement Ingredients
Red Horse Gummies Introduces RedHorse Performance Gummies a Multi-Ingredient Dietary Supplement for Vitality and Daily Energy
Boehringer Ingelheim registers Phase III trial investigating verducatib in COPD
Denali Therapeutics Receives 2026 Prix Galien USA Award for AVLAYAH® (tividenofusp alfa-eknm) as Best Biotechnology Product
Why Kraig Labs’ Spider Silk Could Have a Future in Aerospace
NeOnc’s Ambitious Brain Cancer Plans are Setting the Stage
Pelthos Therapeutics to Combine with Castle Creek Biosciences, Creating Transformative Biotechnology Company Focused on Serious Diseases that Affect the Skin
Second Intangible Cultural Heritage and Healthy Living Conference Held in Dong'e, Shandong
Akari Therapeutics to Highlight Novel RNA-Splicing ADC Payload Strategy at the 3rd Annual ADC Payload Summit
Syndax’s Revuforj® (revumenib) Wins Prestigious 2026 Prix Galien USA Award for Best Product for Rare/Orphan Diseases
Press Release Biocartis NV: Biocartis to Present Initial Development Data for Ultra-Rapid Idylla™ Breast21 Assay at SABCS 2026
Alps Group Inc Announces Shareholder Approval for a Share Consolidation, Share Capital Increase, and Adoption of Second Amended and Restated Memorandum and Articles of Association
Femasys Appoints John Moorhead to Board of Directors
BioNexus Launches New Corporate Website with Expanded Business and Investor Resources
Atsena Therapeutics Reports New Preclinical Data Demonstrating Robust MYO7A Expression and Favorable Safety for ATSN-301, a Laterally Spreading Dual AAV Vector-based Gene Therapy for Usher Syndrome Type 1B

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

World Wellness Times

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.